The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...
They can live in your home and, according to research published in the National Library of Medicine, up to 20 million people in the United States deal with dust mite allergies. Dust mites loves ...
An oral immunotherapy designed to treat dust mite allergy, made by Denmark's ALK-Abello, could soon become an option for thousands of people seeking treatment for persistent symptoms through the NHS.
The National Institute for Healthcare and Care Excellence (NICE) green-lit the daily tablet in draft guidance, after it was shown to reduce debilitating symptoms caused by dust mite allergies.
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...